AM
Amarantus BioScience Holdings, Inc.
AMBS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $36.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.39x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 83.17%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 4,995.23%
FCF margin 4,719.67%
Quality
14 /100
Poor ROIC 4.85%
ROA 46.65%
Asset turnover 0.01x
Debt
70 /100
Low Current ratio 0.00x
Net debt/EBITDA -4.22x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -4.42x
EPS volatility 679.53%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AMBS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Wesley Commissiong
Employees
12
Headquarters
New York City